Bladder. Risk and prognostic factors--a pathologist's perspective. Review uri icon

Overview

abstract

  • Morphology remains a power tool to help predict the risk of recurrence, progression, and even response to therapy in bladder cancer. Nevertheless, more work is needed to refine and standardize criteria and terminology. Novel molecular tools may reveal prognostic factors, but these techniques must be compared with standard morphologic and clinical markers by performing multivariate analysis in a prospective fashion.

publication date

  • August 1, 1999

Research

keywords

  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 0032851925

PubMed ID

  • 10494286

Additional Document Info

volume

  • 26

issue

  • 3